Myeloma Marketplace

Due to current health and safety precautions, hard copy mailing of IMF publications and merchandise are temporarily delayed up to several weeks. However, digital versions of all IMF publications are available to download now.

Myeloma Merchandise & Free Publications

Select a category or use the search box below to find a product.

Understanding Pomalyst® (pomalidomide) capsules
Understanding Pomalyst® (pomalidomide) capsules

Pomalyst® (pomalidomide) in combination with Dexamethasone was approved by the U.S. Food and Drug Administration (FDA) on February 8, 2013 for relapsed and refractory myeloma.
Purchase this product